BioMarin Pharmaceutical Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2013
Total Assets: $2.24B
Liabilities Breakdown FY2013
Total Liabilities: $903.0M
Asset Breakdown
Total Assets: $2.24B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $568.8M | 25.3% |
| Accounts Receivable | $117.8M | 5.3% |
| Inventory | $162.6M | 7.2% |
| Property, Plant & Equipment | $319.3M | 14.2% |
| Goodwill | $54.3M | 2.4% |
| Intangible Assets | $163.1M | 7.3% |
| Other Assets | $858.1M | 38.2% |
Liabilities Breakdown
Total Liabilities: $903.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $36.9M | 4.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $866.1M | 95.9% |